Subscribe

Thonburi Medical Centre Public Company Limited (KDH.BK)

THB83.25 +0.00 (+0.00%)
TH SET Healthcare Medical - Care Facilities
Address 337, Somdet Prachao Taksin Road 10600
Bangkok, TH
CEO Jukkrapun Sukapunphotaram
IPO 2000-01-17
ISIN TH0162010Y09

Explore sections of this company profile

Description

Thonburi Medical Centre Public Company Limited, established in 1977 and headquartered in Bangkok, Thailand, is a prominent healthcare provider operating hospitals throughout the country. The company delivers a broad spectrum of medical and aesthetic services, including treatments for hair loss, comprehensive weight management, sexual wellness, facial enhancements, and cosmetic surgery. Additionally, it offers specialized services for promoting hair growth in areas such as eyebrows, mustaches, beards, and sideburns. The organization was formerly recognized as Krungdhon Hospital Public Company Limited until its rebranding in April 2013.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
THB83.25 +0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
221
Beta
0.12
Float Shares
4.20M
Free Float %
21.7%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.00% +0.00% +3.07% -0.30% +3.70% +3.70% -1.18% -9.68% +1.82% -23.98% +115.33%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
83.25
DCF (Unlevered) 341.62 +310.3%
DCF (Levered) 410.39 +393.0%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM)
Rating 2024-11 Change
Strong Buy 0 0
Buy 0 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
7.27
Safe zone
Piotroski F-Score
5 / 9
Average
MOAT Score
5 / 10
Developing
Composite Rating
A+
Overall Score
5 / 5
High
DCF Score
5 / 5
High
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
4 / 5
High
P/E Score
3 / 5
Medium
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
  • Revenue growth Medical - Care Facilities: +10.2%
    +11.3% Q1'26: +4.7% (vs Q1'25)
  • EPS growth Medical - Care Facilities: +19.2%
    +8.1% Q1'26: +15.8% (vs Q1'25)
  • FCF margin FCF growth · Medical - Care Facilities: +32.0%
    +12.5% Q1'26: +11.9% (vs Q1'25)
  • EBIT margin Medical - Care Facilities: +11.3%
    +15.0% Q1'26: +17.4% (vs Q1'25)
  • ROIC Medical - Care Facilities: +6.8%
    +70.9% Q1'26: +80.9% (vs Q1'25)
  • Share dilution Medical - Care Facilities: +0.0%
    +0.0% Q1'26: +0.0% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×
    0.04× Q1'26: 0.02× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.11) × ERP
WACC = 100% × Ke + 0% × Kd (5.6%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Intrinsic value (base): 341.62 Current price: 83.25
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-27 A+ 5/5 5/5 5/5 5/5 4/5 3/5 3/5
2026-05-08 A+ 5/5 5/5 5/5 5/5 3/5 3/5 4/5
2026-04-24 A 4/5 5/5 4/5 5/5 3/5 3/5 3/5
2026-04-20 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
168.26M
OE per share TTM
8.68
Owner's Yield
10.33%
Maintenance CapEx ratio
20.46%
Maint CapEx / Avg PPE
27.8%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
Total invested
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
189.1K
Shares Outstanding
19.38M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Athabandhu Boonta CFO & Company Secretary male
Jukkrapun Sukapunphotaram Chief Executive Officer male
Nivat Jeegungwal MD & Director
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits